Clinical Trial: Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title:

Brief Summary: The aim of this study is to evaluate the safety and efficacy of iAPA-DC/CTL combined gemcitabine therapy on advanced pancreatic cancer.

Detailed Summary:
Sponsor: Changhai Hospital

Current Primary Outcome: 6-month SR [ Time Frame: 6 months ]

6 months survival rate


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • PFS [ Time Frame: 6 months ]
    progression-Free Survival
  • OS [ Time Frame: 6 months ]
    Over survival
  • ORR [ Time Frame: 2 months ]
    Objective Response Rate
  • QOL [ Time Frame: 2 months ]
    Quality of Life


Original Secondary Outcome: Same as current

Information By: Changhai Hospital

Dates:
Date Received: August 18, 2015
Date Started: June 2015
Date Completion: December 2019
Last Updated: August 19, 2015
Last Verified: January 2015